ArticleMolecular therapy. Methods & clinical development2020

Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology.

Sonali P Barwe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.